A 20-year-old female patient who is HIV-positive has a new prescription for efavirenz ( Sustiva ). Which information about the patient is most important to communicate to the prescribing physician before administering the efavirenz?

Question

Quizplus · Accepted Answer

Efavirenz can cause fetal anomalies and should not be used in patients who may be pregnant. The patient's nausea, use of another nucleoside reverse transcriptase inhibitor, and cd4+ count also should be communicated to the physician, but the most important information is that the patient may potentially be pregnant.

A 20-Year-Old Female Patient Who Is HIV-Positive Has a New